Skip to main content

Table 1 Patient characteristics on admission

From: Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study

 

Shock non-survivors

Shock survivors

Sepsis survivors

Number

10

57

11

Females/Males

2/8

24/33

6/5

Age, years

1.1 (0.6-2.2)a,b

4.1 (1.8-9.3)c

6.1 (2.8-11.4)c

PRISM score

31 (25-35)d,e

21 (16-28)e,f

9 (8-11)d,f

Inotropic medication, number (percentage)

10 (100%)

57 (100%)

2 (18%)

Vasopressor score

3 (3-3)

2 (1-3)

0 (0-1)

Mechanical ventilation, number (percentage)

10 (100%)

37 (65%)

2 (18%)

Steroid treatment, number (percentage)

2 (20%)

6 (11%)

1 (9%)

Prednisolone equivalents, mg/kg

0.9 (0.2-1.6)

2.4 (0.6-4.5)

1.0

Glucose intake, mg/kg per minute

3.3 (0-5.8)

3.9 (1.4-5.0)

1.1 (0.6-3.1)

  1. Data are expressed as median (25th-75th percentile) unless indicated otherwise. The vasopressor score was developed by Hatherill and colleagues [26]. acompared with shock survivors, P < 0.05; bcompared with sepsis survivors, P < 0.05; ccompared with shock non-survivors, P < 0.05; dcompared with shock survivors, P < 0.001; ecompared with sepsis survivors, P < 0.001; fcompared with shock non-survivors, P < 0.001. PRISM, pediatric risk of mortality.
Back to article page

Critical Care

ISSN: 1364-8535